Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Long-Term Debt Issuances (2016 - 2018)

Historic Long-Term Debt Issuances for Capricor Therapeutics (CAPR) over the last 9 years, with Q2 2018 value amounting to -$139140.0.

  • Capricor Therapeutics' Long-Term Debt Issuances fell 15565.6% to -$139140.0 in Q2 2018 from the same period last year, while for Sep 2019 it was -$139140.0, marking a year-over-year decrease of 15565.6%. This contributed to the annual value of $318160.0 for FY2020, which is N/A changed from last year.
  • As of Q2 2018, Capricor Therapeutics' Long-Term Debt Issuances stood at -$139140.0, which was down 15565.6% from $139140.0 recorded in Q1 2018.
  • Capricor Therapeutics' Long-Term Debt Issuances' 5-year high stood at $4.7 million during Q2 2014, with a 5-year trough of -$139140.0 in Q2 2018.
  • Over the past 4 years, Capricor Therapeutics' median Long-Term Debt Issuances value was $514177.0 (recorded in 2014), while the average stood at $1.2 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first crashed by 2032.96% in 2014, then plummeted by 15565.6% in 2018.
  • Quarter analysis of 4 years shows Capricor Therapeutics' Long-Term Debt Issuances stood at $514177.0 in 2014, then skyrocketed by 240.35% to $1.8 million in 2016, then tumbled by 85.71% to $250000.0 in 2017, then plummeted by 155.66% to -$139140.0 in 2018.
  • Its Long-Term Debt Issuances stands at -$139140.0 for Q2 2018, versus $139140.0 for Q1 2018 and $250000.0 for Q4 2017.